QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)

Fortress Value Acquisition Corp. II (FAII) Competitors

Notice: This company has been marked as potentially delisted and may not be actively trading.

FAII vs. BKD, QURE, KOD, CGC, HOWL, STRO, ACIU, ME, AKBA, and SBTX

Should you be buying Fortress Value Acquisition Corp. II stock or one of its competitors? The main competitors of Fortress Value Acquisition Corp. II include Brookdale Senior Living (BKD), uniQure (QURE), Kodiak Sciences (KOD), Canopy Growth (CGC), Werewolf Therapeutics (HOWL), Sutro Biopharma (STRO), AC Immune (ACIU), 23andMe (ME), Akebia Therapeutics (AKBA), and Silverback Therapeutics (SBTX). These companies are all part of the "medical" sector.

Fortress Value Acquisition Corp. II vs.

Brookdale Senior Living (NYSE:BKD) and Fortress Value Acquisition Corp. II (NYSE:FAII) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

Brookdale Senior Living received 459 more outperform votes than Fortress Value Acquisition Corp. II when rated by MarketBeat users. However, 100.00% of users gave Fortress Value Acquisition Corp. II an outperform vote while only 66.96% of users gave Brookdale Senior Living an outperform vote.

CompanyUnderperformOutperform
Brookdale Senior LivingOutperform Votes
462
66.96%
Underperform Votes
228
33.04%
Fortress Value Acquisition Corp. IIOutperform Votes
3
100.00%
Underperform Votes
No Votes

Fortress Value Acquisition Corp. II has lower revenue, but higher earnings than Brookdale Senior Living.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Brookdale Senior Living$3.02B0.35-$189.01M-$0.84-6.65
Fortress Value Acquisition Corp. IIN/AN/A-$13.61MN/AN/A

In the previous week, Brookdale Senior Living had 9 more articles in the media than Fortress Value Acquisition Corp. II. MarketBeat recorded 9 mentions for Brookdale Senior Living and 0 mentions for Fortress Value Acquisition Corp. II. Fortress Value Acquisition Corp. II's average media sentiment score of 0.37 beat Brookdale Senior Living's score of 0.00 indicating that Brookdale Senior Living is being referred to more favorably in the media.

Company Overall Sentiment
Brookdale Senior Living Neutral
Fortress Value Acquisition Corp. II Neutral

Brookdale Senior Living currently has a consensus price target of $7.50, suggesting a potential upside of 34.17%. Given Fortress Value Acquisition Corp. II's higher probable upside, equities analysts plainly believe Brookdale Senior Living is more favorable than Fortress Value Acquisition Corp. II.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Brookdale Senior Living
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Fortress Value Acquisition Corp. II
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

64.3% of Fortress Value Acquisition Corp. II shares are owned by institutional investors. 1.5% of Brookdale Senior Living shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Fortress Value Acquisition Corp. II has a net margin of 0.00% compared to Fortress Value Acquisition Corp. II's net margin of -6.27%. Brookdale Senior Living's return on equity of 0.00% beat Fortress Value Acquisition Corp. II's return on equity.

Company Net Margins Return on Equity Return on Assets
Brookdale Senior Living-6.27% -44.01% -3.75%
Fortress Value Acquisition Corp. II N/A N/A N/A

Summary

Brookdale Senior Living beats Fortress Value Acquisition Corp. II on 7 of the 13 factors compared between the two stocks.


Get Fortress Value Acquisition Corp. II News Delivered to You Automatically

Sign up to receive the latest news and ratings for FAII and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FAII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FAII vs. The Competition

MetricFortress Value Acquisition Corp. IINursing & Personal Care Facilities IndustryMedical SectorNYSE Exchange
Market Cap$299.72M$512.38M$4.90B$17.70B
Dividend YieldN/AN/A5.37%3.55%
P/E RatioN/A23.92265.8125.15
Price / SalesN/A0.252,952.336.73
Price / CashN/A5.3632.7015.39
Price / Book57.921.564.475.46
Net Income-$13.61M-$64.55M$112.57M$981.71M

Fortress Value Acquisition Corp. II Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BKD
Brookdale Senior Living
3.99 of 5 stars
$5.91
+4.2%
$7.50
+26.9%
+61.4%$1.12B$3.02B-7.0425,200
QURE
uniQure
3.1626 of 5 stars
$6.75
+5.8%
$39.17
+480.2%
-73.6%$322.72M$106.48M-1.41501Analyst Report
Analyst Revision
News Coverage
Positive News
KOD
Kodiak Sciences
4.0799 of 5 stars
$6.14
+3.0%
$6.75
+9.9%
-7.5%$322.17MN/A-1.19116
CGC
Canopy Growth
2.0838 of 5 stars
$3.53
+1.7%
$4.87
+37.9%
-85.9%$321.64M$362.24M-0.231,621Short Interest ↑
HOWL
Werewolf Therapeutics
2.6876 of 5 stars
$7.91
+7.6%
$10.58
+33.7%
+161.2%$321.62M$16.40M-7.1946Gap Up
STRO
Sutro Biopharma
4.2689 of 5 stars
$5.26
+9.6%
$14.00
+166.2%
-14.5%$320.61M$48.64M-1.81298Positive News
ACIU
AC Immune
1.96 of 5 stars
$3.79
+0.5%
$16.00
+322.2%
+60.4%$320.07M$4.12M-4.26126Short Interest ↑
Gap Up
ME
23andMe
1.9125 of 5 stars
$0.66
+3.1%
$1.75
+164.1%
-78.7%$319.98M$299.49M-0.60769
AKBA
Akebia Therapeutics
4.0017 of 5 stars
$1.64
+8.6%
$4.50
+174.4%
+77.2%$326.16M$292.60M-5.13204Short Interest ↓
News Coverage
SBTX
Silverback Therapeutics
0 of 5 stars
$8.82
+0.8%
N/A-4.4%$318.03MN/A-3.6483High Trading Volume

Related Companies and Tools

This page (NYSE:FAII) was last updated on 3/4/2024 by MarketBeat.com Staff